BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30417211)

  • 1. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
    Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
    Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.
    Özkan A; Yağcı Küpeli B; Küpeli S; Sezgin G; Bayram İ
    Childs Nerv Syst; 2024 Jun; 40(6):1671-1680. PubMed ID: 38478066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
    Fleischhack G; Massimino M; Warmuth-Metz M; Khuhlaeva E; Janssen G; Graf N; Rutkowski S; Beilken A; Schmid I; Biassoni V; Gorelishev SK; Kramm C; Reinhard H; Schlegel PG; Kortmann RD; Reuter D; Bach F; Iznaga-Escobar NE; Bode U
    J Neurooncol; 2019 May; 143(1):107-113. PubMed ID: 30830679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.
    Bartels U; Wolff J; Gore L; Dunkel I; Gilheeney S; Allen J; Goldman S; Yalon M; Packer RJ; Korones DN; Smith A; Cohen K; Kuttesch J; Strother D; Baruchel S; Gammon J; Kowalski M; Bouffet E
    Neuro Oncol; 2014 Nov; 16(11):1554-9. PubMed ID: 24847085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
    Massimino M; Biassoni V; Miceli R; Schiavello E; Warmuth-Metz M; Modena P; Casanova M; Pecori E; Giangaspero F; Antonelli M; Buttarelli FR; Potepan P; Pollo B; Nunziata R; Spreafico F; Podda M; Anichini A; Clerici CA; Sardi I; De Cecco L; Bode U; Bach F; Gandola L
    J Neurooncol; 2014 Jun; 118(2):305-312. PubMed ID: 24696052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported outcomes of children with newly diagnosed high-grade gliomas treated with nimotuzumab and irinotecan.
    Sirachainan N; Boongird A; Swangsilpa T; Klaisuban W; Lusawat A; Hongeng S
    Childs Nerv Syst; 2017 Jun; 33(6):893-897. PubMed ID: 28439659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution.
    Chiang KL; Chang KP; Lee YY; Huang PI; Hsu TR; Chen YW; Chang FC; Wong TT
    Childs Nerv Syst; 2010 Aug; 26(8):1035-41. PubMed ID: 20217098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
    Rizzo D; Scalzone M; Ruggiero A; Maurizi P; Attinà G; Mastrangelo S; Lazzareschi I; Ridola V; Colosimo C; Caldarelli M; Balducci M; Riccardi R
    J Chemother; 2015 Feb; 27(2):106-10. PubMed ID: 25466729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
    Yang QY; Shen D; Sai K; Mu YG; Jiang XB; Zhang XH; Chen ZP
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):232-5. PubMed ID: 21575527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric diffuse intrinsic pontine glioma patients from a single center.
    Kebudi R; Cakir FB; Agaoglu FY; Gorgun O; Ayan I; Darendeliler E
    Childs Nerv Syst; 2013 Apr; 29(4):583-8. PubMed ID: 23224361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma.
    Sirachainan N; Pakakasama S; Visudithbhan A; Chiamchanya S; Tuntiyatorn L; Dhanachai M; Laothamatas J; Hongeng S
    Neuro Oncol; 2008 Aug; 10(4):577-82. PubMed ID: 18559468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.
    Cohen KJ; Heideman RL; Zhou T; Holmes EJ; Lavey RS; Bouffet E; Pollack IF
    Neuro Oncol; 2011 Apr; 13(4):410-6. PubMed ID: 21345842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.
    Bouffet E; Raquin M; Doz F; Gentet JC; Rodary C; Demeocq F; Chastagner P; Lutz P; Hartmann O; Kalifa C
    Cancer; 2000 Feb; 88(3):685-92. PubMed ID: 10649264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: First results in Chinese patients.
    Wang Y; Pan L; Sheng XF; Chen S; Dai JZ
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e23-9. PubMed ID: 24571331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
    Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
    BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review.
    Parenrengi MA; Suryaningtyas W; Al Fauzi A; Hafid Bajamal A; Kusumastuti K; Utomo B; Muslim Hidayat Thamrin A; Sulistiono B
    Cancer Control; 2022; 29():10732748211053927. PubMed ID: 35191733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma.
    Sharp JR; Bouffet E; Stempak D; Gammon J; Stephens D; Johnston DL; Eisenstat D; Hukin J; Samson Y; Bartels U; Tabori U; Huang A; Baruchel S
    Eur J Cancer; 2010 Dec; 46(18):3271-9. PubMed ID: 20656474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.
    Kim CY; Kim SK; Phi JH; Lee MM; Kim IA; Kim IH; Wang KC; Jung HL; Lee MJ; Cho BK
    J Neurooncol; 2010 Nov; 100(2):193-8. PubMed ID: 20309719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
    Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
    J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.